Page last updated: 2024-08-23

acetylshikonin and Carcinoma, Lewis Lung

acetylshikonin has been researched along with Carcinoma, Lewis Lung in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ahn, KS; Jung, MH; Kim, DK; Kim, JY; Kim, SH; Lee, EO; Lee, HJ; Magesh, V; Nam, D	1

Other Studies

1 other study(ies) available for acetylshikonin and Carcinoma, Lewis Lung

Article	Year
Shikonin, acetylshikonin, and isobutyroylshikonin inhibit VEGF-induced angiogenesis and suppress tumor growth in lewis lung carcinoma-bearing mice. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2008, Volume: 128, Issue:11 Topics: Animals; Anthraquinones; Anti-Inflammatory Agents, Non-Steroidal; Carcinoma, Lewis Lung; Cell Movement; Cells, Cultured; Depression, Chemical; Dose-Response Relationship, Drug; Down-Regulation; Endothelial Cells; Female; Humans; Lithospermum; Mice; Naphthoquinones; Neovascularization, Pathologic; Urokinase-Type Plasminogen Activator; Vascular Endothelial Growth Factor A	2008

Article

Year

Shikonin, acetylshikonin, and isobutyroylshikonin inhibit VEGF-induced angiogenesis and suppress tumor growth in lewis lung carcinoma-bearing mice.

Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2008, Volume: 128, Issue:11

Topics: Animals; Anthraquinones; Anti-Inflammatory Agents, Non-Steroidal; Carcinoma, Lewis Lung; Cell Movement; Cells, Cultured; Depression, Chemical; Dose-Response Relationship, Drug; Down-Regulation; Endothelial Cells; Female; Humans; Lithospermum; Mice; Naphthoquinones; Neovascularization, Pathologic; Urokinase-Type Plasminogen Activator; Vascular Endothelial Growth Factor A

2008